142 related articles for article (PubMed ID: 36421014)
1. A novel 4'-brominated derivative of fisetin induces cell cycle arrest and apoptosis and inhibits EGFR/ERK1/2/STAT3 pathways in non-small-cell lung cancer without any adverse effects in mice.
Sabarwal A; van Rooyen JC; Caburet J; Avgenikos M; Dheeraj A; Ali M; Mishra D; de Meester JSB; Stander S; van Otterlo WAL; Kaschula CH; Singh RP
FASEB J; 2022 Dec; 36(12):e22654. PubMed ID: 36421014
[TBL] [Abstract][Full Text] [Related]
2. Flavonol isolated from ethanolic leaf extract of Thuja occidentalis arrests the cell cycle at G2-M and induces ROS-independent apoptosis in A549 cells, targeting nuclear DNA.
Mukherjee A; Sikdar S; Bishayee K; Boujedaini N; Khuda-Bukhsh AR
Cell Prolif; 2014 Feb; 47(1):56-71. PubMed ID: 24267912
[TBL] [Abstract][Full Text] [Related]
3. Kaempferol and Fisetin-Related Signaling Pathways Induce Apoptosis in Head and Neck Cancer Cells.
Kubina R; Krzykawski K; Dziedzic A; Kabała-Dzik A
Cells; 2023 Jun; 12(12):. PubMed ID: 37371038
[TBL] [Abstract][Full Text] [Related]
4. Erratum to "A novel 4'-brominated derivative of fisetin induces cell cycle arrest and apoptosis and inhibits EGFR/ERK1/2/ STAT3 pathways in non-small-cell lung cancer without any adverse effects in mice".
FASEB J; 2023 Jan; 37(1):e22725. PubMed ID: 36527405
[No Abstract] [Full Text] [Related]
5. Fisetin inhibits laryngeal carcinoma through regulation of AKT/NF-κB/mTOR and ERK1/2 signaling pathways.
Zhang XJ; Jia SS
Biomed Pharmacother; 2016 Oct; 83():1164-1174. PubMed ID: 27551764
[TBL] [Abstract][Full Text] [Related]
6. Fisetin Deters Cell Proliferation, Induces Apoptosis, Alleviates Oxidative Stress and Inflammation in Human Cancer Cells, HeLa.
Afroze N; Pramodh S; Shafarin J; Bajbouj K; Hamad M; Sundaram MK; Haque S; Hussain A
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163629
[TBL] [Abstract][Full Text] [Related]
7. Fisetin induces apoptosis and endoplasmic reticulum stress in human non-small cell lung cancer through inhibition of the MAPK signaling pathway.
Kang KA; Piao MJ; Madduma Hewage SR; Ryu YS; Oh MC; Kwon TK; Chae S; Hyun JW
Tumour Biol; 2016 Jul; 37(7):9615-24. PubMed ID: 26797785
[TBL] [Abstract][Full Text] [Related]
8. Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model.
Diaz R; Nguewa PA; Parrondo R; Perez-Stable C; Manrique I; Redrado M; Catena R; Collantes M; Peñuelas I; Díaz-González JA; Calvo A
BMC Cancer; 2010 May; 10():188. PubMed ID: 20459769
[TBL] [Abstract][Full Text] [Related]
9. Lymecycline reverses acquired EGFR-TKI resistance in non-small-cell lung cancer by targeting GRB2.
Chen Y; Wu J; Yan H; Cheng Y; Wang Y; Yang Y; Deng M; Che X; Hou K; Qu X; Zou D; Liu Y; Zhang Y; Hu X
Pharmacol Res; 2020 Sep; 159():105007. PubMed ID: 32561477
[TBL] [Abstract][Full Text] [Related]
10. Carnosic acid and fisetin combination therapy enhances inhibition of lung cancer through apoptosis induction.
Shi B; Wang LF; Meng WS; Chen L; Meng ZL
Int J Oncol; 2017 Jun; 50(6):2123-2135. PubMed ID: 28440400
[TBL] [Abstract][Full Text] [Related]
11. A novel STAT3 inhibitor W2014-S regresses human non-small cell lung cancer xenografts and sensitizes EGFR-TKI acquired resistance.
Zheng Q; Dong H; Mo J; Zhang Y; Huang J; Ouyang S; Shi S; Zhu K; Qu X; Hu W; Liu P; Wang Y; Zhang X
Theranostics; 2021; 11(2):824-840. PubMed ID: 33391507
[TBL] [Abstract][Full Text] [Related]
12. Tangeretin derivative, 5-acetyloxy-6,7,8,4'-tetramethoxyflavone induces G2/M arrest, apoptosis and autophagy in human non-small cell lung cancer cells in vitro and in vivo.
Li YR; Li S; Ho CT; Chang YH; Tan KT; Chung TW; Wang BY; Chen YK; Lin CC
Cancer Biol Ther; 2016; 17(1):48-64. PubMed ID: 26569090
[TBL] [Abstract][Full Text] [Related]
13. FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway.
Ravi J; Sneh A; Shilo K; Nasser MW; Ganju RK
Oncotarget; 2014 May; 5(9):2475-86. PubMed ID: 24811863
[TBL] [Abstract][Full Text] [Related]
14. Induction of G2/M Cell Cycle Arrest via p38/p21
Pai JT; Hsu MW; Leu YL; Chang KT; Weng MS
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500594
[TBL] [Abstract][Full Text] [Related]
15. Fisetin inhibits growth, induces G₂ /M arrest and apoptosis of human epidermoid carcinoma A431 cells: role of mitochondrial membrane potential disruption and consequent caspases activation.
Pal HC; Sharma S; Elmets CA; Athar M; Afaq F
Exp Dermatol; 2013 Jul; 22(7):470-5. PubMed ID: 23800058
[TBL] [Abstract][Full Text] [Related]
16. ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models.
Kang HN; Kim SH; Yun MR; Kim HR; Lim SM; Kim MS; Hong KW; Kim SM; Kim H; Pyo KH; Park HJ; Han JY; Youn HA; Chang KH; Cho BC
Lung Cancer; 2016 May; 95():57-64. PubMed ID: 27040853
[TBL] [Abstract][Full Text] [Related]
17. Dual inhibition of phosphatidylinositol 3-kinase/Akt and mammalian target of rapamycin signaling in human nonsmall cell lung cancer cells by a dietary flavonoid fisetin.
Khan N; Afaq F; Khusro FH; Mustafa Adhami V; Suh Y; Mukhtar H
Int J Cancer; 2012 Apr; 130(7):1695-705. PubMed ID: 21618507
[TBL] [Abstract][Full Text] [Related]
18. Natural flavonol fisetin attenuated hyperuricemic nephropathy via inhibiting IL-6/JAK2/STAT3 and TGF-β/SMAD3 signaling.
Ren Q; Tao S; Guo F; Wang B; Yang L; Ma L; Fu P
Phytomedicine; 2021 Jul; 87():153552. PubMed ID: 33994251
[TBL] [Abstract][Full Text] [Related]
19. Activation of ERK and Mutual Regulation of Stat3 and SP1 Contribute to Inhibition of PDK1 Expression by Atractylenolide-1 in Human Lung Cancer Cells.
Xiao Q; Zheng F; Wu J; Tang Q; Wang W; Hann SS
Cell Physiol Biochem; 2017; 43(6):2353-2366. PubMed ID: 29073620
[TBL] [Abstract][Full Text] [Related]
20. Fisetin Inhibits Cell Proliferation through the Induction of G
Tsai YH; Lin JJ; Ma YS; Peng SF; Huang AC; Huang YP; Fan MJ; Lien JC; Chung JG
Am J Chin Med; 2019; 47(4):841-863. PubMed ID: 31096772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
